Q4 2025 earnings call recap: revenue growth, 2026 guidance, Simeox & CPAP expansion, margins, and $30M buyback—read key takeaways.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results